An Update on the Epidemiology and Clinicodemographic Features of Meniere's Disease.

Autor: De Ravin E; Department of Otolaryngology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Quimby AE; Department of Otolaryngology and Communication, SUNY Upstate Medical University, Syracuse, New York, USA., Bartellas M; Department of Otolarynology - Head & Neck Surgery, University of Ottawa, Ottawa, Ontario, USA., Swanson S; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Hwa TP; Department of Otorhinolarynoglogy - Head & Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bigelow DC; Department of Otorhinolarynoglogy - Head & Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Brant JA; Department of Otorhinolarynoglogy - Head & Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA., Ruckenstein MJ; Department of Otorhinolarynoglogy - Head & Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jazyk: angličtina
Zdroj: The Laryngoscope [Laryngoscope] 2024 Jul; Vol. 134 (7), pp. 3310-3315. Date of Electronic Publication: 2024 Jan 18.
DOI: 10.1002/lary.31282
Abstrakt: Objective: To characterize the estimated prevalence and clinicodemographic features of Ménière's disease (MD) using current diagnostic criteria.
Methods: A cross-sectional study was undertaken at our tertiary academic referral center. All patients seen in Otolaryngology clinic with ICD-10 diagnoses of MD, from January 1, 2013 to July 31, 2022 were identified. Chart review was undertaken to determine the estimated prevalence of MD meeting AAO-HNS diagnostic criteria. Clinicodemographic features were evaluated against a comparator group without MD seen in our health system.
Results: Of 806 ICD-10 diagnoses of MD, we identified 480 MD cases meeting diagnostic criteria (168 definite). Mean age at presentation for MD cases was 49 years. Forty-seven percent of cases were male. A significantly higher proportion of MD cases than comparators were white (76% vs. 66%, p < 0.001). Mean time since MD symptom onset was 6.7 years, with a mean attack duration of 4.6 h; 7.5% of MD cases reported a positive family history, and 7% had bilateral disease. The odds of reporting migraine were significantly greater among MD patients than comparators (OR 1.74 [1.26-2.42]); the odds of having autoimmune conditions were lower (OR 0.45 [0.28-0.74]); and the odds of reporting allergies were no different (OR 0.96 [0.74-1.25]) versus comparator patients after controlling for demographic characteristics.
Conclusions: Among MD diagnoses, there is a low estimated prevalence of MD meeting diagnostic criteria, and an even lower prevalence of definite MD. Compared to a comparator group of patients seen for any disorder, patients with MD are more likely to be white, male, and have a history of migraine.
Level of Evidence: 4 Laryngoscope, 134:3310-3315, 2024.
(© 2024 The American Laryngological, Rhinological and Otological Society, Inc.)
Databáze: MEDLINE